Information date: 20 October 2026 — China regulates dual-use items under the Export Control Law and the consolidated dual-use export control list administered by MOFCOM and the General Administration of Customs; exporters must classify the item, screen the end user, and obtain a licence before shipment, with statutory review periods for the licence application and a separate clearance step at customs. Knowing that statement is not enough for an operating, research or compliance decision. The team must first establish who and what it applies to, how the effect reaches the real process, and which evidence would justify action.
Verified facts and scope
China regulates dual-use items under the Export Control Law and the consolidated dual-use export control list administered by MOFCOM and the General Administration of Customs; exporters must classify the item, screen the end user, and obtain a licence before shipment, with statutory review periods for the licence application and a separate clearance step at customs.
Confirm first: the exact technical parameters of the item, the commodity code and control-list entry, the destination country, whether any party appears on a Chinese control or unreliable-entity list, and whether the transaction is a re-export of imported technology; each of these changes whether a licence is required at all.
How the effect reaches operations
Licensing is parameter-driven, not product-name-driven: the same description can be controlled or uncontrolled depending on performance thresholds, so classification must be done at specification level. End-user documentation is the second gate — a valid licence still fails at customs if the end-user certificate, import certificate or final-use statement does not match the consignee and consignee's declared purpose.
The common error is treating an earlier general permit or a supplier's own classification as conclusive for a new product revision. Another is using a template end-user statement that describes a broad business purpose rather than the specific end use, which triggers a request for supplementary materials and resets the clock.
For “FAQ: China's Dual-Use Export Licensing — Control-List Look-Up, End-User Certificates and Clearance Timelines”, official rules or published findings, direct evidence from the relevant product or process, and assumptions that remain untested should be recorded separately. A broad source defines the external boundary; it does not replace batch records, protocols, contracts, labels or direct observations.
Decision
If the item sits near a threshold parameter or the end user is new, apply for classification or pre-ruling before quoting a delivery date; if the item is clearly outside the list, keep the screening record on file; if the end user is in a sensitive sector, budget the full statutory review period plus customs clearance time instead of assuming a fast track.
Implementation checklist
- Classify at parameter level and record the list entry or the negative finding.
- Obtain an end-user statement naming the specific final use and the consignee of record.
- Align the commercial contract delivery date with the licence review plus clearance window.
- Assign one decision owner, one implementation owner and a dated review point for “FAQ: China's Dual-Use Export Licensing — Control-List Look-Up, End-User Certificates and Clearance Timelines”.
- For “FAQ: China's Dual-Use Export Licensing — Control-List Look-Up, End-User Certificates and Clearance Timelines”, archive the source page, access date, applicable population or entity, and internal evidence both supporting and opposing the current decision.
- When a rule, formulation, supplier, protocol or observed result changes, reopen only the affected question in “FAQ: China's Dual-Use Export Licensing — Control-List Look-Up, End-User Certificates and Clearance Timelines”.
Evidence and review
For “FAQ: China's Dual-Use Export Licensing — Control-List Look-Up, End-User Certificates and Clearance Timelines”, start with one real case rather than an abstract checklist. Record the input version, responsible owner, start time, observed result and stop condition. If the team cannot complete “Classify at parameter level and record the list entry or the negative finding.” with current evidence, it should not expand the process to more products, patients, suppliers or markets. The first review should focus only on facts capable of changing the decision.
The second control follows “Obtain an end-user statement naming the specific final use and the consignee of record.”. Keep the source date, applicable population or entity, deadline, cost effect and owner in the same evidence file. A wording preference does not justify a new version. A repeated discrepancy, an unsupported health claim or a regulatory mismatch does: correct that point and hold release until the evidence is available.
After “Align the commercial contract delivery date with the licence review plus clearance window.”, compare the intended outcome with what actually happened. Apply the same success criteria to each later expansion. If only one number, date or responsibility changes, update that field and the affected conclusion instead of recreating evidence that remains valid. This keeps the decision traceable without turning review into an open-ended rewrite cycle.
Limits of the conclusion
This is a procedural overview, not a legal opinion on classification or licensability; whether a specific item requires a licence depends on its technical parameters and the current version of the control list, which changes.
